Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
13.8M
-
Shares change
-
+636K
-
Total reported value, excl. options
-
$440M
-
Value change
-
+$16.4M
-
Number of buys
-
61
-
Number of sells
-
-75
-
Price
-
$31.84
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q4 2017
162 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q4 2017.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.8M shares
of 22.7M outstanding shares and own 60.93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.27M shares), Conestoga Capital Advisors, LLC (1.33M shares), DIMENSIONAL FUND ADVISORS LP (1.01M shares), Vanguard Group Inc (926K shares), Epoch Investment Partners, Inc. (743K shares), JANUS HENDERSON GROUP PLC (613K shares), AWM Investment Company, Inc. (504K shares), STATE STREET CORP (488K shares), Ranger Investment Management, L.P. (384K shares), and THOMSON HORSTMANN & BRYANT INC (357K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.